Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-23
1988-06-14
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546112, A61K 31435, C07D47104
Patent
active
047512350
ABSTRACT:
7-(indolizin-2-yl)hept-6-enoic acids of the formula I: ##STR1## wherein each of R.sup.1 and R.sup.2 is, independently, H, alkyl, cycloalkyl, aralkyl or aryl, ##STR2## in which R.sup.8 is H, an ester residue or cation; or the lactone thereof. The compounds are useful as hypocholesteremic agents.
REFERENCES:
patent: 4248889 (1981-02-01), Oka et al.
patent: 4255444 (1981-03-01), Oka et al.
patent: 4375475 (1983-03-01), Willard et al.
patent: 4474971 (1984-10-01), Wareing
patent: 4520026 (1985-05-01), Rosseels et al.
Dentz Bernard I.
Kassenoff Melvyn M.
Sandoz Pharm. Corp.
Schwartz Richard A.
Sharkin Gerald D.
LandOfFree
Anti-atherosclerotic indolizine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-atherosclerotic indolizine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-atherosclerotic indolizine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505328